Thyroid cancer, nonmedullary, 2: genes and variants
Explore variant evidence for Thyroid cancer, nonmedullary, 2 across 3 analyzed proteins (HRAS, NKX2-1, PTEN). Linked ClinVar records include 4 pathogenic or likely pathogenic variants, 6 variants of uncertain significance and 0 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-10-21. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Thyroid cancer, nonmedullary, 2
HRAS: GTPase HRas
Its GTP-bound state activates RAF-MEK-ERK and other pathways downstream of growth-factor receptors. Somatic activating variants drive several cancers, while germline activating variants cause Costello syndrome.
3 ClinVar pathogenic / likely pathogenic and 6 uncertain variants in HRAS have source records linked to Thyroid cancer, nonmedullary, 2. Association strength is not clinical gene validity.
NKX2-1: Homeobox protein Nkx-2.1
It controls developmental and tissue-specific gene programs in lung, thyroid, and basal ganglia. Haploinsufficiency causes brain-lung-thyroid syndrome, variably combining chorea or developmental movement disorder, neonatal respiratory disease, and thyroid dysfunction.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in NKX2-1 have source records linked to Thyroid cancer, nonmedullary, 2. Association strength is not clinical gene validity.
PTEN: Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN
A lipid and protein phosphatase that removes phosphate groups from signaling molecules, especially PIP3. By opposing the PI3K-AKT pathway, it limits cell growth and survival signals, and PTEN variants are associated with Cowden syndrome and multiple cancers.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in PTEN have source records linked to Thyroid cancer, nonmedullary, 2. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Thyroid cancer, nonmedullary, 2
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| HRAS G12C | 12 | Pathogenic / likely pathogenic (★★) | |
| HRAS G13D | 13 | Pathogenic / likely pathogenic (★★) | |
| HRAS Q61R | 61 | Pathogenic / likely pathogenic (★★) | |
| NKX2-1 R161L | 161 | Homeobox | Pathogenic / likely pathogenic (★★) |
Same protein, different disease
- Costello syndrome also has ClinVar records linked to HRAS variants; they fall partly in the same places as the Thyroid cancer, nonmedullary, 2 variants (15 pathogenic / likely pathogenic).
- RASopathy also has ClinVar records linked to HRAS variants; they fall in the same places as the Thyroid cancer, nonmedullary, 2 variants (6 pathogenic / likely pathogenic).
- Large congenital melanocytic nevus also has ClinVar records linked to HRAS variants; they fall in the same places as the Thyroid cancer, nonmedullary, 2 variants (5 pathogenic / likely pathogenic).
- Epidermal nevus also has ClinVar records linked to HRAS variants; they fall in the same places as the Thyroid cancer, nonmedullary, 2 variants (3 pathogenic / likely pathogenic).
- Brain-lung-thyroid syndrome also has ClinVar records linked to NKX2-1 variants; they fall mostly in different places as the Thyroid cancer, nonmedullary, 2 variants (14 pathogenic / likely pathogenic).
- Benign hereditary chorea also has ClinVar records linked to NKX2-1 variants; they fall mostly in different places as the Thyroid cancer, nonmedullary, 2 variants (4 pathogenic / likely pathogenic).
Diseases related to Thyroid cancer, nonmedullary, 2
- Head and neck squamous cell carcinoma, also linked to HRAS and PTEN
- Hypertrophic cardiomyopathy, also linked to HRAS
- RASopathy, also linked to HRAS
- Noonan syndrome, also linked to HRAS
- PTEN hamartoma tumor syndrome, also linked to PTEN
- Cowden syndrome, also linked to PTEN
- Noonan syndrome and Noonan-related syndrome, also linked to HRAS
- Hereditary breast cancer, also linked to PTEN
- Urinary bladder cancer, also linked to HRAS
- Costello syndrome, also linked to HRAS
- Brain-lung-thyroid syndrome, also linked to NKX2-1
- Macrocephaly-autism syndrome, also linked to PTEN
Frequently asked questions
Which genes have records linked to Thyroid cancer, nonmedullary, 2?
This view contains 3 analyzed proteins: HRAS, NKX2-1, PTEN. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 4 pathogenic or likely pathogenic variants, 6 variants of uncertain significance and 0 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 18 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center